Skip to main content
SpringerLink
Log in

QDPR gene mutation and clinical follow-up in Chinese patients with dihydropteridine reductase deficiency

  • Original Article
  • Published:
World Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Background

This study aimed to investigate the mutation spectrum of the QDPR gene, to determine the effect of mutations on dihydropteridine reductase (DHPR) structure/function, to discuss the potential genotypephenotype correlation, and to evaluate the clinical outcome of Chinese patients after treatment.

Methods

Nine DHPR-deficient patients were enrolled in this study and seven of them underwent neonatal screening. QDPR gene mutations were analyzed and confirmed by routine methods. The potential pathogenicity of missense variants was analyzed using Clustal X, PolyPhen program and Swiss-PDB Viewer 4.04_OSX software, respectively. The clinical outcomes of the patients were evaluated after long-term treatment.

Results

In 10 mutations of the 9 patients, 4 were novel mutations (G20V, V86D, G130S and A175R), 4 were reported by us previously, and 2 known mutations were identified. R221X was a hotspot mutation (27.7%) in our patients. Eight missense mutations probably had damage to protein. Six patients in this series were treated with a good control of phenylalanine level. The height and weight of the patients were normal at the age of 4 months to 7.5 years. Four patients, who underwent a neonatal screening and were treated early, showed a normal mental development. In 2 patients diagnosed late, neurological symptoms were significantly improved.

Conclusions

The mutation spectrum of the QDPR gene is different in the Chinese population. Most mutations are related to severe phenotype. The determination of DHPR activity should be performed in patients with hyperphenylalaninemia. DHPR-deficient patients who were treated below the age of 2 months may have a near normal mental development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Werner ER, Blau N, Thöny B. Tetrahydrobiopterin: biochemistry and pathophysiology. Biochem J 2011;438:397–414.

    Article  CAS  PubMed  Google Scholar 

  2. Burke JR, Frey PA. The importance of binding energy in catalysis of hydride transfer by UDP-galactose 4-epimerase: A carbon-13 and nitrogen-15 NMR and kinetic study. Biochemistry 1993;32:13220–13230.

    Article  CAS  PubMed  Google Scholar 

  3. Swanson BA, Frey PA. Identification of lysine 153 as a functionally important residue in UDP-galactose 4-epimerase from Escherichia coli. Biochemistry 1993;32:13231–13236.

    Article  CAS  PubMed  Google Scholar 

  4. Kiefer PM, Varughese KI, Su Y, Xuong NH, Chang CF, Gupta P, et al. Altered Structural and Mechanistic Properties of Mutant Dihydropteridine Reductases. J Biol Chem 1996;271:3437–3444.

    Article  CAS  PubMed  Google Scholar 

  5. Lockyer J, Cook RG, Milstien S, Kaufman S, Woo SL, Ledley FD. Structure and expression of human dihydropteridine reductase. Proc Natl Acad Sci U S A 1987;84:3329–3333.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Opladen T, Hoffmann GF. Blau N. An international survey of patients with tetrahydrobiopterin deficiencies presenting with hyperphenylalaninaemia. J Inherit Metab Dis 2012;35:963–973.

    Article  CAS  PubMed  Google Scholar 

  7. de Sanctis L, Alliaudi C, Spada M, Farrugia R, Cerone R, Biasucci G, et al. Genotype-phenotype correlation in dihydropteridine re ductase deficiency. J Inherit Metab Dis 2000;23:333–337.

    Article  PubMed  Google Scholar 

  8. Thöny B, Auerbach G, Blau N. Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem J 2000;347:1–16.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Kaufman S. Hyperphenylalaninaemia Caused by Defects in Biopterin Metabolism. J Inher Metab Dis 1985;8:20–27.

    Article  CAS  PubMed  Google Scholar 

  10. Ye J, Qiu WJ, Han LS, Zhang HW, Zhou JD, Gao XL, et al. Diagnosis, treatment and gene mutation analysis of the first case with dihydropteridine reductase deficiency in the mainland of China. Zhonghua Er Ke Za Zhi 2008;46:281–285. [in Chinese]

    PubMed  Google Scholar 

  11. Ye J, Yang YL, Yu WM, Zou H, Jiang JH, Yang RL, et al. Demographics, diagnosis and treatment of 256 patients with tetrahydrobiopterin deficiency in mainland China: results of a retrospective, multicentre study. J Inherit Metab Dis 2013;36:893–901.

    Article  PubMed  Google Scholar 

  12. Ye J, Qiu WJ, Zhou JD, Han LS, Gu XF. Development of a method for the determination of dihydropteridine reductase and its application. Jian Yan Yi Xue 2006;21:48–51. [in Chinese]

    CAS  Google Scholar 

  13. Yang N, Han LS, Gu XF, Ye J, Qiu WJ, Zhang HW, et al. Analysis of gene mutations in Chinese patients with maple syrup urine disease. Mol Genet Metab 2012;106:412–418.

    Article  CAS  PubMed  Google Scholar 

  14. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods 2010;7:248–249.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Su Y, Varughese KI, Xuong NH, Bray TL, Roche DJ, Whiteley JM. The crystallographic structure of a human dihydropteridine reductase NADH binary complex expressed in Escherichia coli by a cDNA constructed from its rat homologue. J Biol Chem 1993;268:26836–26841.

    CAS  PubMed  Google Scholar 

  16. Thöny B, Blau N. Mutations in the BH4-metabolizing genes GTP cyclohydrolase I, 6-pyruvoyl-tetrahydropterin synthase, sepiapterin reductase, carbinolamine-4a-dehydratase, and dihydropteridine reductase. Hum Mutat 2006;27:870–878.

    Article  PubMed  Google Scholar 

  17. Ponzone A, Spada M, Ferraris S, Dianzani I, de Sanctis L. Dihydropteridine reductase deficiency in man: from biology to treatment. Med Res Rev 2004;24:127–150.

    Article  CAS  PubMed  Google Scholar 

  18. Gesell A. Monthly increments of development in infancy. J Genet Psychol 1925;32:203–208.

    Google Scholar 

  19. Yilmaz E, Cali F, Roman V, Ozalp I, Coskun T, Tokatli A, et al. Molecular basis of mild hyperphenylalaninemia in Turkey. J Inherit Metab Dis 2000;23:523–525.

    Article  CAS  PubMed  Google Scholar 

  20. Gu XF, Wang ZG, Ye J, Han LS, Qiu WJ. Newborn screening in China: phenylketonuria, congenital hypothyroidism and expanded screening. Ann Acad Med Singap 2008;37:107–114.

    PubMed  Google Scholar 

  21. Ye J, Qiu WJ, Han LS, Zhou JD, Gao XL, Gu XF. The investigation of differential diagnostic development and incidence of tetrahydrobiopterin deficiency. Zhonghua Yu Fang Yi Xue Za Zhi 2009;43:128–131. [in Chinese]

    PubMed  Google Scholar 

  22. Blau N, Burton BK, Thöny B, van Spronsen FJ, Waisbren S. Phenylketonuria and BH4 deficiencies, 1st ed. Bremen: UNIMED Science, 2010.

    Google Scholar 

  23. Smooker PM, Howells DW, Cotton RGH. Identification and in vitro expression of mutations causing dihydropteridine reductase deficiency. Biochemistry 1993;32:6443–6449.

    Article  CAS  PubMed  Google Scholar 

  24. Dianzani I, Howells DW, Ponzone A, Saleeba JA, Smooker PM, Cotton RG. Two new mutations in the dihydropteridine reductase gene in patients with tetrahydrobiopterin deficiency. J Med Genet 1993;30:465–469.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Dianzani I, de Sanctis L, Smooker PM, Gough TJ, Alliaudi C, Brusco A, et al. Dihydropteridine reductase deficiency: physical structure of the QDPR gene, identification of two new mutations and genotype-phenotype correlations. Hum Mutat 1998;12:267–273.

    Article  CAS  PubMed  Google Scholar 

  26. Liu TT, Chiang SH, Wu SJ, Hsiao KJ. Tetrahydrobiopterindeficient hyperphenylalaninemia in the Chinese. Clin Chim Acta 2001;313:157–169.

    Article  CAS  PubMed  Google Scholar 

  27. Blau N. Diagnosis of Inborn Errors of Tetrahydrobiopterin Metabolism. Pteridines 2009;20:64–70.

    CAS  Google Scholar 

  28. Gasnier B. The loading of neurotransmitters into synaptic vesicles. Biochimie 2000;82:327–337.

    Article  CAS  PubMed  Google Scholar 

  29. Lindegren ML, Krishnaswami S, Reimschisel T, Fonnesbeck C, Sathe NA, McPheeters ML. A systematic review of BH4 (Sapropterin) for the adjuvant treatment of phenylketonuria. JIMD Rep 2013;8:109–119.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Ikeda H, Matsubara Y, Mikami H, Kure S, Owada M, Gough T, et al. Molecular analysis of dihydropteridinereductase deficiency: identification of two novel mutations in Japanese patients. Hum Genet 1997;100:637–642.

    Article  CAS  PubMed  Google Scholar 

  31. Pérez B, Rodríguez-Pascau L, Vilageliu L, Grinberg D, Ugarte M, Desviat LR. Present and future of antisense therapy for splicing modulation in inherited metabolic disease. J Inherit Metab Dis 2010;33:397–403.

    Article  PubMed  Google Scholar 

  32. Romstad A, Kalkanoğlu HS, Coşkun T, Demirkol M, Tokatli A, Dursun A, et al. Molecular analysis of 16 Turkish families with DHPR deficiency using denaturing gradient gel electrophoresis (DGGE). Hum Genet 2000;107:546–553.

    Article  CAS  PubMed  Google Scholar 

  33. Varughese KI, Skinner MM, Whiteley JM, Matthews DA, Xuong NH. Crystal structure of rat liver dihydropteridine reductase. Proc Natl Acad Sci U S A 1992;89:6080–6084.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatric Endocrinology and Genetic Metabolism and Shanghai Institute for Pediatric Research, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200092, China

    De-Yun Lu, Jun Ye, Lian-Shu Han, Wen-Juan Qiu, Hui-Wen Zhang, Jian-De Zhou, Pei-Zhong Bao, Ya-Fen Zhang & Xue-Fan Gu

  2. Shanghai Institute for Pediatric Research, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, No.1665 Kong Jiang Road, Shanghai, 200092, China

    Jun Ye

Authors
  1. De-Yun Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jun Ye
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lian-Shu Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wen-Juan Qiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hui-Wen Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jian-De Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Pei-Zhong Bao
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ya-Fen Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Xue-Fan Gu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jun Ye.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lu, DY., Ye, J., Han, LS. et al. QDPR gene mutation and clinical follow-up in Chinese patients with dihydropteridine reductase deficiency. World J Pediatr 10, 219–226 (2014). https://doi.org/10.1007/s12519-014-0496-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12519-014-0496-7

Key words

Search

Navigation